Connect with us
Vytrus Biotech raised €2.3 million through a capital round and share sales, led by Boyser and minority shareholders. The funds will support expansion and new technologies....
The leap to digitalization should serve the German group to boost its growth. Sources from B. Braun advance that the group had a turnover of 615...
Eli Lilly is investing $5.3 billion in a new Indiana plant to increase production of diabetes and weight loss drugs, raising total facility investment to $9...
Merck is acquiring Mirus Bio for $600 million to accelerate growth in revolutionary technologies. CEO Belén Garijo aims to make cell and gene therapies accessible globally....
BaseLaunch, a Basel biotech incubator, gains support from AbbVie, joining Roche, Novo Nordisk, Johnson & Johnson, and CSL Behring. Operated by Basel Area Business & Innovation,...
AstraZeneca aims to nearly double its 2023 sales to $80 billion by 2030, focusing on cancer and rare disease treatments. CEO Pascal Soriot highlighted twelve potential...
Esteve reported a 10% growth in 2023, with net income of €710 million. Revenue grew 2% in Spain, 18% in the EU, and 9% globally, especially...
Until now, in the field of anti-obesity treatments, there was a drug that attracted attention: Ozempic. It is also made by Novo Nordisk and is very...
Goldman Sachs increased its stake in Grifols from 5.8% to 6.4%, amid a bearish attack by Gotham City Research, coinciding with Grifols' Q1 results. Melqart reduced...
In 2023, Spanish biotech companies secured 228 million euros in private financing, a 37% increase from 2022. This was announced at the AseBio Investor Day, organized...
 |
|
 |  |
 |
|